Racura Oncology Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 17, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	433	204	311	200	311	527
Market Cap Growth	128.43%	-34.32%	55.59%	-35.78%	-41.00%	546.75%
Enterprise Value	412	185	297	173	274	522
Last Close Price	2.38	1.18	1.82	1.23	1.95	3.67
PS Ratio	124.41	33.78	64.27	63.73	439.48	1360.92
PB Ratio	18.35	12.75	16.97	7.84	8.62	38.42
P/TBV Ratio	20.42	15.14	20.05	8.92	9.50	52.37
EV/Sales Ratio	118.39	30.68	61.43	55.32	387.06	1346.52
Net Debt / Equity Ratio	-0.89	-0.85	-0.94	-0.84	-0.93	-0.68
Net Debt / EBITDA Ratio	2.67	3.08	1.29	2.11	3.07	1.53
Asset Turnover	0.15	0.32	0.21	0.10	0.03	0.04
Quick Ratio	18.15	9.42	9.26	20.16	23.71	18.07
Current Ratio	18.37	10.29	9.32	20.44	24.10	20.24
Return on Equity (ROE)	-42.40%	-27.89%	-63.10%	-32.22%	-44.96%	-65.32%
Return on Assets (ROA)	-21.91%	-15.63%	-36.41%	-20.41%	-27.05%	-39.39%
Return on Capital Employed (ROCE)	-34.50%	-29.40%	-74.40%	-41.10%	-31.00%	-46.30%
Earnings Yield	-2.17%	-2.34%	-4.45%	-4.97%	-3.60%	-1.20%
Buyback Yield / Dilution	-2.69%	-4.81%	-2.35%	-4.83%	-17.06%	-22.86%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.